Advertisement

Topics

$VERU First Patient Enrolled in Phase 2 Study of Zuclomiphene Citrate for Treatment of Hot Flashes Caused by Androgen Deprivation Therapy https://globenewswire.com/news-release/2018/10/01/1587647/0/en/First-Patient-Enrolled-in-Phase-2-Study-of-Zuclomiphe

08:34 EDT 1 Oct 2018 | Odi Bruckman

First Patient Enrolled in Phase 2 Study of Zuclomiphene Citrate for Treatment of Hot Flashes Caused by Androgen Deprivation Therapy https://globenewswire.com/news-release/2018/10/01/1587647/0/en/First-Patient-Enrolled-in-Phase-2-Study-of-Zuclomiphene-Citrate-for-Treatment-of-Hot-Flashes-Caused-by-Androgen-Deprivation-Therapy.html …

Original Article: $VERU First Patient Enrolled in Phase 2 Study of Zuclomiphene Citrate for Treatment of Hot Flashes Caused by Androgen Deprivation Therapy https://globenewswire.com/news-release/2018/10/01/1587647/0/en/First-Patient-Enrolled-in-Phase-2-Study-of-Zuclomiphe

NEXT ARTICLE

More From BioPortfolio on "$VERU First Patient Enrolled in Phase 2 Study of Zuclomiphene Citrate for Treatment of Hot Flashes Caused by Androgen Deprivation Therapy https://globenewswire.com/news-release/2018/10/01/1587647/0/en/First-Patient-Enrolled-in-Phase-2-Study-of-Zuclomiphe"

Advertisement
Quick Search
Advertisement
Advertisement